Screening of TACE Peptide Inhibitors from Phage Display Peptide Library

Summary: To obtain the recombinant tumor necrosis factor-α converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (TS00) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expres....

Full description

Saved in:
Bibliographic Details
Published inJournal of Huazhong University of Science and Technology. Medical sciences Vol. 25; no. 5; pp. 473 - 476
Main Author 黄巍 李凌波 韩玲 杨渝珍
Format Journal Article
LanguageEnglish
Published China Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 2005
Wuhan Institute of Medical Sciences,Wuhan 430014,China%Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Subjects
Online AccessGet full text
ISSN1672-0733
1993-1352
DOI10.1007/BF02895991

Cover

Abstract Summary: To obtain the recombinant tumor necrosis factor-α converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (TS00) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expres.sion plasmids were constructed by inserting T800 and T1300 into plasmid pET-28a and pET-28c respectively. The recombinant TS00 and T1300 were induced by IPTG, and SDS-PAGE and Western blotting analysis results revealed that TS00 and T1300 were highly expressed in the form of inclusion body. After Ni^2+-NTA resin affinity chromatography, the recombinant proreins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSRPYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF-α release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3%. FACS analysis revealed that the peptide mediated the accumulation of TNF-α on the cell surface. These results demonstrate that the TACE binding peptide is an effective antagonist of TACE.
AbstractList Summary: To obtain the recombinant tumor necrosis factor-α converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (TS00) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expres.sion plasmids were constructed by inserting T800 and T1300 into plasmid pET-28a and pET-28c respectively. The recombinant TS00 and T1300 were induced by IPTG, and SDS-PAGE and Western blotting analysis results revealed that TS00 and T1300 were highly expressed in the form of inclusion body. After Ni^2+-NTA resin affinity chromatography, the recombinant proreins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSRPYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF-α release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3%. FACS analysis revealed that the peptide mediated the accumulation of TNF-α on the cell surface. These results demonstrate that the TACE binding peptide is an effective antagonist of TACE.
To obtain the recombinant tumor necrosis factor-alpha converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (T800) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expression plasmids were constructed by inserting T800 and T1300 into plasmid pET-28a and pET-28c respectively. The recombinant T800 and T1300 were induced by IPTG, and SDS-PAGE and Western blotting analysis results revealed that T800 and T1300 were highly expressed in the form of inclusion body. After Ni(2+)-NTA resin affinity chromatography, the recombinant proteins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSRPYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF-alpha release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3%. FACS analysis revealed that the peptide mediated the accumulation of TNF-alpha on the cell surface. These results demonstrate that the TACE-binding peptide is an effective antagonist of TACE.
To obtain the recombinant tumor necrosis factor-alpha converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (T800) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expression plasmids were constructed by inserting T800 and T1300 into plasmid pET-28a and pET-28c respectively. The recombinant T800 and T1300 were induced by IPTG, and SDS-PAGE and Western blotting analysis results revealed that T800 and T1300 were highly expressed in the form of inclusion body. After Ni(2+)-NTA resin affinity chromatography, the recombinant proteins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSRPYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF-alpha release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3%. FACS analysis revealed that the peptide mediated the accumulation of TNF-alpha on the cell surface. These results demonstrate that the TACE-binding peptide is an effective antagonist of TACE.To obtain the recombinant tumor necrosis factor-alpha converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (T800) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expression plasmids were constructed by inserting T800 and T1300 into plasmid pET-28a and pET-28c respectively. The recombinant T800 and T1300 were induced by IPTG, and SDS-PAGE and Western blotting analysis results revealed that T800 and T1300 were highly expressed in the form of inclusion body. After Ni(2+)-NTA resin affinity chromatography, the recombinant proteins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSRPYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF-alpha release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3%. FACS analysis revealed that the peptide mediated the accumulation of TNF-alpha on the cell surface. These results demonstrate that the TACE-binding peptide is an effective antagonist of TACE.
R4; To obtain the recombinant tumor necrosis factor-α converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (T800) and full-length ectodomain (T1300) of TACE were amplified by RTPCR, and the expression plasmids were constructed by inserting T800 and T1300 into plasmid pET28a and pET-28c respectively. The recombinant T800 and T1300 were induced by IPTG, and SDSPAGE and Western blotting analysis results revealed that T800 and T1300 were highly expressed in the form of inclusion body. After Ni2+-NTA resin affinity chromatography, the recombinant proteins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSRPYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF-α release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3 %. FACS analysis revealed that the peptide mediated the accumulation of TNF-α on the cell surface. These results demonstrate that the TACE-binding peptide is an effective antagonist of TACE.
To obtain the recombinant tumor necrosis factor- alpha converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide inhibitors, the cDNA coding catalytic domain (T800) and full-length ectodomain (T1300) of TACE were amplified by RT-PCR, and the expression plasmids were constructed by inserting T800 and T1300 into plasmid pET-28a and pET-28c respectively. The recombinant T800 and T1300 were induced by IPTG, and SDS-PAGE and Western blotting analysis results revealed that T800 and T1300 were highly expressed in the form of inclusion body. After Ni super(2+)-NTA resin affinity chromatography, the recombinant proteins were used in the screening of TACE-binding peptides from phage display peptide library respectively. After 4 rounds of biopanning, the positive phage clones were analyzed by ELISA, competitive inhibition assay and DNA sequencing. A common amino acid sequence (TRWLVYFSR-PYLVAT) was found and synthesized. The synthetic peptide could inhibit the TNF- alpha release from LPS-stimulated human peripheral blood mononuclear cells (PBMC) up to 60.3%. FACS analysis revealed that the peptide mediated the accumulation of TNF- alpha on the cell surface. These results demonstrate that the TACE-binding peptide is an effective antagonist of TACE.
Author 黄巍 李凌波 韩玲 杨渝珍
AuthorAffiliation Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China Wuhan Institute of Medical Sciences, Wuhan 430014 , China
AuthorAffiliation_xml – name: Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;Wuhan Institute of Medical Sciences,Wuhan 430014,China%Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Author_xml – sequence: 1
  fullname: 黄巍 李凌波 韩玲 杨渝珍
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16463648$$D View this record in MEDLINE/PubMed
BookMark eNp9kVtrGzEQhUVJaC7tS39AWfqQQsq2uq129Zg6VzA00PRZSKuRLWctOdKaxv--CnZTKCHoYfTwzZk5c47QXogBEPpA8FeCcfvt-yWmnWykJG_QIZGS1YQ1dK_8RUtr3DJ2gI5yXmDctILyt-iACC6Y4N0huvrZJ4Dgw6yKrro7m1xUt7AavYXqJsy98WNMuXIpLqvbuZ5Bde7zatCbZ2rqTdJp8w7tOz1keL-rx-jX5cXd5Lqe_ri6mZxN657KhtTGWqOpLksKhntDW9lQ11mqnZGWc2xBSt6BEB1pO8f7xmHbdbYDCwyYxewYfdnq_tbB6TBTi7hOoUxU42Jzbx8fjQJajJaHSaE_b-lVig9ryKNa-tzDMOgAcZ1VOY2ULcOykCevkkRyyYl4kvy4A9dmCVatkl8W_-rvSQuAt0CfYs4JnOr9qEcfw5i0HxTB6ik19S-10nL6X8uz6kvwpx08j2H2UJJTRvf3zg-gaLEtSFnkD9l6n8k
CitedBy_id crossref_primary_10_3390_ijms10125442
Cites_doi 10.4049/jimmunol.159.9.4524
10.1016/0076-6879(93)17065-D
10.1074/jbc.275.19.14608
10.1016/S0014-5793(03)01159-1
10.1038/385733a0
10.1038/385729a0
ClassificationCodes R4
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
8FD
FR3
P64
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1007/BF02895991
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic

Engineering Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Screening of TACE Peptide Inhibitors from Phage Display Peptide Library
EISSN 1993-1352
EndPage 476
ExternalDocumentID tjykdxxb_e200505001
16463648
10_1007_BF02895991
20506146
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: The National Natural Sciences Foundation of China; 湖北省卫生厅科研项目
  funderid: (30070722); (JX1B098)
GroupedDBID -5E
-5G
-BR
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29K
29~
2B.
2C~
2J2
2JN
2KG
2KM
2LR
2RA
2~H
30V
4.4
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
92F
92I
92L
95-
95.
95~
96X
AAAVM
AABHQ
AAJKR
AANXM
AARHV
AARTL
AAYIU
AAYQN
AAYTO
ABFTV
ABJOX
ABKCH
ABMNI
ABNWP
ABQBU
ABTMW
ACGFS
ACHXU
ACKNC
ACOMO
ACSNA
ACUDM
ADHIR
ADINQ
ADKPE
ADURQ
ADYFF
ADZKW
AEBTG
AEGNC
AEJHL
AEKMD
AEOHA
AEPYU
AETLH
AEXYK
AFWTZ
AFZKB
AGAYW
AGDGC
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIIXL
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
ARMRJ
AZFZN
B-.
BA0
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
D-I
EBS
EJD
ESBYG
FA0
FEDTE
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GQ6
GQ7
H13
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IPNFZ
IXD
I~X
I~Z
J-C
JBSCW
JUIAU
KOV
M4Y
MA-
N2Q
NDZJH
NQJWS
NU0
O9-
O93
O9I
O9J
P9S
PF0
QOR
QOS
R-E
R89
R9I
RIG
ROL
RPX
RSV
S..
S16
S1Z
S27
S37
S3B
SAP
SCL
SDH
SHX
SMD
SNE
SNX
SOJ
SPISZ
SZ9
SZN
T13
TCJ
TGQ
TSG
TT1
TUC
U2A
U9L
UG4
VC2
W48
W91
WK8
Z7U
Z82
Z8V
ZOVNA
~A9
~WA
AAYXX
ABJNI
ABQSL
ADHKG
AGQPQ
CITATION
DPUIP
CGR
CUY
CVF
ECM
EIF
NPM
7QO
8FD
FR3
P64
7X8
4A8
93N
PSX
ID FETCH-LOGICAL-c2951-bddba2a199630cb27952f8d2afb9d440de9948e668178f4c5f0d88d8ede3e3d03
ISSN 1672-0733
IngestDate Thu May 29 04:06:47 EDT 2025
Fri Jul 11 15:17:51 EDT 2025
Fri Jul 11 05:52:01 EDT 2025
Thu Jan 02 21:59:41 EST 2025
Tue Aug 05 11:58:52 EDT 2025
Thu Apr 24 22:55:48 EDT 2025
Fri Nov 25 19:17:14 EST 2022
IsPeerReviewed false
IsScholarly false
Issue 5
Keywords tumor necrosis factor-α converting enzyme
phage display
ectodomain
prokaryote expression
peptide inhibitor
Language English
License http://www.springer.com/tdm
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2951-bddba2a199630cb27952f8d2afb9d440de9948e668178f4c5f0d88d8ede3e3d03
Notes tumor necrosis factor-α converting enzyme
R978.1
tumor necrosis factor-α converting enzyme; ectodomain; prokaryote expression; phage display; peptide inhibitor
42-1679/R
phage display
ectodomain
prokaryote expression
peptide inhibitor
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 16463648
PQID 19494161
PQPubID 23462
PageCount 4
ParticipantIDs wanfang_journals_tjykdxxb_e200505001
proquest_miscellaneous_733997309
proquest_miscellaneous_19494161
pubmed_primary_16463648
crossref_citationtrail_10_1007_BF02895991
crossref_primary_10_1007_BF02895991
chongqing_backfile_20506146
PublicationCentury 2000
PublicationDate 2005-00-00
PublicationDateYYYYMMDD 2005-01-01
PublicationDate_xml – year: 2005
  text: 2005-00-00
PublicationDecade 2000
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Journal of Huazhong University of Science and Technology. Medical sciences
PublicationTitleAlternate Journal of Zuazhong University of Science and Technology: Medical Edition
PublicationTitle_FL JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY(MEDICAL SCIENCES)
PublicationYear 2005
Publisher Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Wuhan Institute of Medical Sciences,Wuhan 430014,China%Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Publisher_xml – name: Wuhan Institute of Medical Sciences,Wuhan 430014,China%Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
– name: Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
References R A Black (BF02895991_CR1) 1997; 385
M L Moss (BF02895991_CR2) 1997; 385
P Reddy (BF02895991_CR7) 2000; 275
K A Solomon (BF02895991_CR6) 1997; 159
N Srour (BF02895991_CR3) 2003; 554
K L Zhu (BF02895991_CR4) 2003; 19
G P Smith (BF02895991_CR5) 1993; 217
9034191 - Nature. 1997 Feb 20;385(6618):733-6
9379053 - J Immunol. 1997 Nov 1;159(9):4524-31
9034190 - Nature. 1997 Feb 20;385(6618):729-33
14623079 - FEBS Lett. 2003 Nov 20;554(3):275-83
10799547 - J Biol Chem. 2000 May 12;275(19):14608-14
7682645 - Methods Enzymol. 1993;217:228-57
References_xml – volume: 19
  start-page: 752
  issue: 11
  year: 2003
  ident: BF02895991_CR4
  publication-title: Chin J Immunol (Chinese)
– volume: 159
  start-page: 4524
  year: 1997
  ident: BF02895991_CR6
  publication-title: J Immunol
  doi: 10.4049/jimmunol.159.9.4524
– volume: 217
  start-page: 228
  year: 1993
  ident: BF02895991_CR5
  publication-title: Method Enzymol
  doi: 10.1016/0076-6879(93)17065-D
– volume: 275
  start-page: 14608
  issue: 19
  year: 2000
  ident: BF02895991_CR7
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.19.14608
– volume: 554
  start-page: 275
  issue: 3
  year: 2003
  ident: BF02895991_CR3
  publication-title: FEBS Lett
  doi: 10.1016/S0014-5793(03)01159-1
– volume: 385
  start-page: 733
  issue: 6618
  year: 1997
  ident: BF02895991_CR2
  publication-title: Nature
  doi: 10.1038/385733a0
– volume: 385
  start-page: 729
  issue: 6618
  year: 1997
  ident: BF02895991_CR1
  publication-title: Nature
  doi: 10.1038/385729a0
– reference: 9034190 - Nature. 1997 Feb 20;385(6618):729-33
– reference: 14623079 - FEBS Lett. 2003 Nov 20;554(3):275-83
– reference: 7682645 - Methods Enzymol. 1993;217:228-57
– reference: 10799547 - J Biol Chem. 2000 May 12;275(19):14608-14
– reference: 9034191 - Nature. 1997 Feb 20;385(6618):733-6
– reference: 9379053 - J Immunol. 1997 Nov 1;159(9):4524-31
SSID ssj0057624
Score 1.3655401
Snippet Summary: To obtain the recombinant tumor necrosis factor-α converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE...
To obtain the recombinant tumor necrosis factor-alpha converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide...
To obtain the recombinant tumor necrosis factor- alpha converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide...
R4; To obtain the recombinant tumor necrosis factor-α converting enzyme (TACE) ectodomain and use it as a selective molecule for the screening of TACE peptide...
SourceID wanfang
proquest
pubmed
crossref
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 473
SubjectTerms ADAM Proteins - antagonists & inhibitors
ADAM Proteins - biosynthesis
ADAM Proteins - genetics
ADAM17 Protein
Catalytic Domain
Escherichia coli - genetics
Escherichia coli - metabolism
Genetic Vectors - genetics
Humans
Leukocytes, Mononuclear - cytology
Peptide Library
Peptides - chemistry
Peptides - pharmacology
Prokaryotic Cells - metabolism
Recombinant Proteins - biosynthesis
Recombinant Proteins - genetics
Tumor Necrosis Factor-alpha - antagonists & inhibitors
图书馆
外周血
抗生素
缩氨酸
肿瘤坏死因子-α转化酶
Title Screening of TACE Peptide Inhibitors from Phage Display Peptide Library
URI http://lib.cqvip.com/qk/85740A/20055/20506146.html
https://www.ncbi.nlm.nih.gov/pubmed/16463648
https://www.proquest.com/docview/19494161
https://www.proquest.com/docview/733997309
https://d.wanfangdata.com.cn/periodical/tjykdxxb-e200505001
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKeOEFgfgK2yASe0EoU-I4H36spo6CxnggFeUpsmObhk1poa209a_nLnGSVtvEx0tUWa6T3v16Pl9-d0fIUShMkmrOvEL6icdCkXoiNLEXq4QZLo0SAnOHP53H4wn7OI2mg8GHLdbSeiWPi82teSX_o1UYA71iluw_aLZbFAbgM-gXrqBhuP6Vjr8UyJqxvOVseDJ6t0CSisJCILNSlnUnnTqBZDFDbo4ql4tLcd3NsiGcOxzU8VpsZtiKaJe80VoDjLj3gfnj7pWP3VOXPWBsSPqrLjv6T2njAd_lvLeBVTvYmSL7zW_rzcymrLUBimjLmsYJUlubShetuaXRFqyiLdvJmp4mN2y63zLV4WwY8aa3127h7PPP-enk7CzPRtPsHrlPkyRAdueEDttNGU5VTX_j9ol2K9XalbG-Bsr1J_zSXT_lxuGjzvGqDIhhyx3JHpGHVk3usAHFYzLQ1RPyvgOEOzcuAsK1qnZ7QLgICLcGhGsB0c2ygHhKJqej7GTs2U4ZXkHBRfakUlJQgYzy0C8kTXhETaqoMJIrxnylOWepjuM0SFLDisj4Kk1VqpUOdaj88BnZq-aVfkFccC-Nr4soTGjBhAgkDWIFxwJcVoNz7pD9TkbgaRUXWD8sp36EoYXYIW9bqeWFLTKPvU4u87Y8di9th7zp5i6a0iq3znrdCj8Hy4evs0Sl5-tlHnDG8XjuEPeOGaBnzmEL4w553qitv1GMlfJY6pAjq8fc_rGX-erH9YW6upK5pnWjR_DkXv75HvvkQV3Wtw7PHZC91a-1PgSHdSVf1VD8DWJhmLg
linkProvider Springer Nature
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Screening+of+TACE+peptide+inhibitors+from+phage+display+peptide+library&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Huang%2C+Wei&rft.au=Li%2C+Lingbo&rft.au=Han%2C+Ling&rft.au=Yang%2C+Yuzhen&rft.date=2005&rft.issn=1672-0733&rft.volume=25&rft.issue=5&rft.spage=473&rft_id=info:doi/10.1007%2FBF02895991&rft.externalDBID=NO_FULL_TEXT
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg